Cargando…
1024. Evaluation of Atovaquone Prescribing for Pneumocystis jiroveci Pneumonia (PJP) Prophylaxis
BACKGROUND: Trimethoprim-sulfamethoxazole (TMP-SMX) use for PJP prophylaxis has been associated with a variety of adverse reactions including myelosuppression, hypersensitivity reactions, acute kidney injury, and hyperkalemia. Atovaquone is used as an alternative drug, but it has several disadvantag...
Autores principales: | Aleissa, Muneerah, Kubiak, David, Nauffal, Mary, Sommer, Jamie, Patterson, Monica, Marty, Francisco M, Pearson, Jeffrey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6811155/ http://dx.doi.org/10.1093/ofid/ofz360.888 |
Ejemplares similares
-
HTLV-1-Associated Adult T Cell Leukemia Lymphoma Presenting as Granulomatous Pneumocystis Jiroveci Pneumonia (PJP) and Hypercalcemia
por: Shahnaz, Sabiha, et al.
Publicado: (2007) -
Pneumocystis jiroveci Pneumonia
por: Haque, Abida K., et al.
Publicado: (2008) -
The Pathogenesis and Diagnosis of Pneumocystis jiroveci Pneumonia
por: Apostolopoulou, Anna, et al.
Publicado: (2022) -
Risk factors for Pneumocystis jirovecii pneumonia (PJP) in kidney transplantation recipients
por: Lee, Su Hwan, et al.
Publicado: (2017) -
336. COVID-19 and Pneumocystis jiroveci Pneumonia
por: Saling, Christopher, et al.
Publicado: (2021)